Radioligand Therapy Market to Surge with 13.1% CAGR: Projected Growth from $2.6B in 2025 to $4.8B by 2030 - Novartis' Pluvicto and Lutathera Have Catalyzed Commercial Momentum

The "Radioligand Therapeutics in Cancer Treatment: Global Markets" has been added to ResearchAndMarkets.com's offering.The global market for radioligand therapeutics in cancer treatment is poised for ...

Fuel Cells for Residential, Commercial and Military Power: Global Market Set to More Than Double During 2025-2030 Reaching USD 10.7 Billion

The "Market for Fuel Cells for Residential, Commercial and Military Power" has been added to ResearchAndMarkets.com's offering. The global market for fuel cells for residential, commercial, and ...